Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention)

PHASE2CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

February 28, 2013

Conditions
Thyroiditis, Autoimmune
Interventions
DIETARY_SUPPLEMENT

Anatabloc Supplement

Product, as mint-flavored lozenges (3 mg anatabine per lozenge), to be taken 3 times each day

DIETARY_SUPPLEMENT

Placebo

Placebo, as mint flavored lozenges, to be taken 3 times each day

Trial Locations (9)

33401

Metabolic Research Institute, Inc., West Palm Beach

33542

Florida Medical Clinic, P.A., Zephyrhills

48322

Associated Endocrinologists, P.C., West Bloomfield

60561

Robert J. Becker, M.D., LTD, La Grange

75231

North Texas Endocrine Center, Dallas

Research Institute of Dallas, Dallas

78681

Texas Diabetes & Endocrinology, Round Rock

78731

Texas Diabetes & Endocrinology, Austin

07012

New Jersey Physicians, LLC, Clifton

All Listed Sponsors
lead

Rock Creek Pharmaceuticals, Inc.

INDUSTRY

NCT01551498 - Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention) | Biotech Hunter | Biotech Hunter